SESSION 2 – CHALLENGES OF BRINGING NEW TRETMENTS TO THE CLINIC
Saturday, July 17, 2021
7:00 AM San Francisco | 9:00 AM Chicago | 10:00 AM New York
Session 2 Highlights
- Breaking news on late stage molecules
- The Innovators’ story: Decisions from the C-Suite
- Office or surgery based extended duration anti-VEGF?
- Delivery platforms that will change our practice
*Agenda coming soon!